Leezole VG Vaginal Softgel Capsule contains a combination of Clindamycin 100mg and Clotrimazole 200mg, formulated for the effective treatment of mixed vaginal infections caused by susceptible bacteria and fungi. Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby exerting a bacteriostatic effect against anaerobic bacteria and certain gram-positive cocci. Clotrimazole is an imidazole antifungal agent that disrupts fungal cell membrane synthesis by inhibiting the enzyme lanosterol 14-α-demethylase, leading to increased membrane permeability and fungal cell death. This dual-action softgel capsule is indicated for bacterial vaginosis and vulvovaginal candidiasis, providing broad-spectrum antimicrobial coverage. The vaginal route of administration ensures targeted delivery, minimizing systemic exposure and side effects. Leezole VG is typically administered once daily at bedtime for a duration of 7 days, or as directed by a healthcare professional. Patients should complete the full course of therapy to prevent recurrence and resistance. Contraindications include hypersensitivity to clindamycin, clotrimazole, or any component of the formulation. Use with caution in pregnant or breastfeeding women, and consult a healthcare provider before use. Common adverse effects may include local irritation, burning sensation, or itching.